ir.rewalk.comInvestors | ReWalk Robotics Ltd

Skip to main navigation Home FAQs Contact Products About Products ReStore Exo-Suit ReStore Exo-Suit FAQs ReWalk Personal 6.0 ReWalk FAQs ReWalker Testimonials ReWalk Clinical Publications ReWalk™ Personal 6.0 Exoskeleton Solutions for Spinal Cord Injury The ReStore™ Soft Exo-Suit Solutions for Stroke Rehabilitation Close Newsroom Media and Press Releases ReWalk in the News Events Gallery Events ReWalk in the News Close Company About ReWalk Robotics Management Board of Directors Contact Management Board of Directors Close Locations All locations ReWalk for Spinal Cord Injury ReStore for Stroke Rehabilitation All locations Close Investors Corporate Profile Stock Information Analyst Coverage Financial Information Corporate Governance Webcasts & Presentations Events Calendar Investor FAQs Information Requests Press Releases Stock Information Close Investors ReWalk / Investors / Investors Investors Corporate Profile ReWalk Robotics (Nasdaq: RWLK) is an innovative medical device company that is designs, develops and commercializes robotic devices that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. We have developed and are continuing to commercialize our ReWalk Personal and ReWalk Rehabilitation devices for individuals with Spinal Cord Injury, or SCI Products, which are exoskeletons designed for individuals with paraplegia that use our patented tilt sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. We began marketing ReWalk Rehabilitation for use in hospitals, rehabilitation centers and stand-alone training centers in the United States and Europe in 2011, and we received FDA clearance to market ReWalk Personal in the United States in June 2014. We have also developed and began commercializing our ReStore device in June 2019, following receipt of CE mark and FDA clearance in the second quarter of 2019. ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke. Our principal markets are the United States and Europe. In Europe, we have a direct sales operation in Germany and the United Kingdom and work with distribution partners in certain other major countries. We operate our business from our offices in Marlborough, Massachusetts, Berlin, Germany and Yokneam, Israel. Symbol RWLK (Common Stock) 3 Mo. 6 Mo. Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases more Summary Toggle ReWalk Robotics Repays Outstanding Balance on Kreos Credit Line — 01/06/21 Read More Summary Toggle ReWalk Robotics Donates ReStore Exo-Suit to Brooks Rehabilitation to Support Stroke Survivors — 12/21/20 Read More Summary Toggle Leading German Private Health Insurer Enters Contract to Provide ReWalk Exoskeletons to Individuals with Spinal Cord Injuries — 12/10/20 Read More Events more There are currently no events to display. Print Page RSS Feeds E-mail Alerts IR Contacts Phone numbers USA +1 (508) 251-1154 Germany +49 (0) 30-2589-5080 Israel +(972) 4-959-0123 Products About Products New ReWalk™ Personal 6.0 ReWalk™ Rehabilitation FAQs Clinical Publications Active Clinical Studies ReWalkers Testimonials Gallery News Events Video Coverage Print Coverage Press Releases Company About ReWalk Robotics Management Board of Directors Contact Locations Training Centers Distributors All locations Investors Corporate Profile Stock Information Analyst Coverage Financial Information Corporate Governance Webcasts & Presentations Events Calendar Investor FAQs Information Requests Press Releases © 2021 ReWalks Robotics Disclaimer Contact...